COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,870 Articles (22,568 medRxiv, 8,302 bioRxiv)

Most recent first Previous |  Page 1522: Articles 15211-15220  | Next

Longitudinal Changes in COVID-19 Associated In-Hospital Mortality
Warner, F., Hitchings, M. D., Cummings, D. A., McPadden, J., Krumholz, H. M., Ko, A. I., Schulz, W. L.
10.1101/2021.05.04.21255938 — Posted: 2021-05-04
Mouse Adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
Muruato, A., Vu, M., Johnson, B. A., Davis-Gardner, M., Vanderheiden, A. R., Lokugamage, K., Schindewolf, C., Crocquet-Valdes, P. A., Langsjoen, R. M., Plante, J. A., Plante, K. S., Weaver, S. C., Debbink, K., Routh, A. L., Walker, D. H., Suthar, M. S., Shi, P.-Y., Xie, X., Menachery, V. D.
10.1101/2021.05.03.442357 — Posted: 2021-05-04
ORAI1 establishes resistance to SARS-CoV-2 infection by regulating tonic type I interferon signaling
Wu, B., Ramaiah, A., Garcia, G., Gwack, Y., Arumugaswami, V., Srikanth, S.
10.1101/2021.05.04.442548 — Posted: 2021-05-04
CCR2-dependent monocyte-derived cells restrict SARS-CoV-2 infection
Vanderheiden, A., Thomas, J., Soung, A. L., Davis-Gardner, M. E., Floyd, K., Jin, F., Cowan, D. A., Pellegrini, K., Creanga, A., Pegu, A., Derrien-Colemyn, A., Shi, P.-Y., Grakoui, A., Klein, R. S., Bosinger, S. E., Kohlmeier, J. E., Menachery, V. D., Suthar, M. S.
10.1101/2021.05.03.442538 — Posted: 2021-05-04
Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipients
Ashokkumar, C., Rohan, V., Kroemer, A. H., Rao, S., Mazariegos, G., Higgs, B. W., Nadig, S., Almeda, J., Dhani, H., Khan, K., Yazigi, N., Ekong, U., Kaufman, S., Betancourt-Garcia, M. M., Mukund, K., Sethi, P., Mehrotra, S., Soltys, K., Singh, M. S., Bond, G., Khanna, A., Ningappa, M., Spishock, B., Sindhi, E., Atale, N., Saunders, M., Baliga, P., Fishbein, T., Subramaniam, S., Sindhi, R.
10.1101/2021.05.03.442371 — Posted: 2021-05-04
Sex-biased response to and brain cell infection by SARS-CoV-2 in a highly susceptible human ACE2 transgenic model
Tsai, C.-Y., Chou, Y.-C., Chen, C.-Y., Jan, J.-T., Chang, M.-L., Lu, L.-A., Huang, P.-Y., Hsu, T.-T., Hsueh, Y.-P.
10.1101/2021.05.04.441029 — Posted: 2021-05-04
A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice
Shapira, T., Monreal, I. A., Dion, S. P., Jager, M., Desilets, A., Olmstead, A. D., Vandal, T., Buchholz, D. W., Imbiakha, B., Gao, G., Chin, A., Rees, W. D., Steiner, T., Nabi, I. R., Marsault, E., Sahler, J., August, A., Van de Walle, G., Whittaker, G. R., Boudreault, P.-L., Aguilar, H. C., Leduc, R., Jean, F.
10.1101/2021.05.03.442520 — Posted: 2021-05-04
Highly functional Cellular Immunity in SARS-CoV-2 Non-Seroconvertors is associated with immune protection
Kilpelainen, A., Jimenez-Moyano, E., Blanch-Lombarte, O., Ouchi, D., Penya, R., Quirant-Sanchez, B., Chamorro, A., Blanco, I., Martinez-Caceres, E., Paredes, R., Mateu, L., Carrillo, J., Blanco, J., Brander, C., Massanella, M., Clotet, B., G Prado, J.
10.1101/2021.05.04.438781 — Posted: 2021-05-04
Protective heterologous T cell immunity in COVID-19 induced by MMR and Tdap vaccine antigens
Mayadas, T., Mysore, V., Cullere, X., Settles, M. L., Kattan, M., Ji, X., Desjardins, M., Durbin-Johnson, B., Gilboa, T., Baden, L., Walt, D., Andrew, L., Jehi, L.
10.1101/2021.05.03.441323 — Posted: 2021-05-04
Semi-supervised identification of SARS-CoV-2 molecular targets
Beck, K. L., Seabolt, E., Agarwal, A., Nayar, G., Bianco, S., Krishnareddy, H., Mukherjee, V., Kaufman, J. H.
10.1101/2021.05.03.440524 — Posted: 2021-05-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).